Trend Direction
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING decreased from FY2025 to FY2026, moving from $669,543 to $99,737 in the ingested records.
- Latest: $99,737
- Previous: $669,543
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
NAICS 325413 includes $11,286,743 in federal contract obligations across 51 ingested award records.
Quick answer
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING has $11,286,743 in ingested federal contract obligations across 51 award records in this naics profile.
NAICS Snapshot
Total obligations$11,286,743
Award records51
Entity code325413
Data updatedMay 7, 2026
Top relationshipROCHE DIAGNOSTICS CORPORATION
Top categoryDepartment of Veterans Affairs
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.
Market Analysis
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING has $11,286,743 across 51 ingested award records, with the analysis below generated only from visible tables on this page.
Concentration
ROCHE DIAGNOSTICS CORPORATION accounts for 18.1% of IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING's visible obligations in this slice, which is the first concentration signal to review before treating the market as broad or fragmented.
- Top relationship: ROCHE DIAGNOSTICS CORPORATION
- Top value: $2,037,903
Buyer And Category Mix
Department of Veterans Affairs is the largest visible secondary category at $6,305,165. Use this alongside the relationship table to separate one-off award activity from repeat market exposure.
- Largest secondary category: Department of Veterans Affairs
- Category value: $6,305,165
Recent Award Signal
The latest displayed award is 36C24722P0546 from FY2023 with $1,791,752 in obligations. Recent rows help identify whether the profile is still active in current procurement data.
- Award date: Not listed
Source caveats
- USAspending records can be revised after initial publication.
- Negative obligations and deobligations may affect totals in narrow slices.
Spending by Fiscal Year
| FY20262 awards | $99,737 |
| FY20258 awards | $669,543 |
| FY20248 awards | $1,423,337 |
| FY20237 awards | $3,389,443 |
| FY20224 awards | $322,377 |
| FY202122 awards | $5,382,306 |
Top Contractors
| ROCHE DIAGNOSTICS CORPORATION4 awards | $2,037,903 |
| ABBOTT LABORATORIES INC.3 awards | $1,972,469 |
| PALOGEN, INC.1 awards | $1,500,000 |
| BIOFIRE DIAGNOSTICS LLC2 awards | $1,360,497 |
| DIASORIN INC2 awards | $962,701 |
| FISHER SCIENTIFIC COMPANY L.L.C.3 awards | $583,101 |
| ABBOTT MOLECULAR INC.1 awards | $579,536 |
| CARDINAL HEALTH 200, LLC2 awards | $501,185 |
| GOVERNMENT SCIENTIFIC SOURCE INC3 awards | $417,452 |
| BIOMERIEUX INC5 awards | $246,031 |
Top Agencies
| Department of Veterans Affairs21 awards | $6,305,165 |
| Department of Health and Human Services28 awards | $4,927,191 |
| Department of Defense2 awards | $54,387 |
Recent Awards
| Award | Recipient | Fiscal year | Obligations | Date |
|---|---|---|---|---|
| 36C24722P0546 | ROCHE DIAGNOSTICS CORPORATION | 2023 | $1,791,752 | Not available |
| 36C25521P0113 | ABBOTT LABORATORIES INC. | 2021 | $1,558,414 | Not available |
| 75N92021C00025 | PALOGEN, INC. | 2021 | $1,500,000 | Not available |
| HHSN269201700022U | BIOFIRE DIAGNOSTICS LLC | 2021 | $1,314,390 | Not available |
| 75N90023P00746 | DIASORIN INC | 2023 | $688,566 | Not available |
| 36C24424F0564 | ABBOTT MOLECULAR INC. | 2024 | $579,536 | Not available |
| 36C24923N0033 | CARDINAL HEALTH 200, LLC | 2023 | $475,894 | Not available |
| 36C26224P1936 | FISHER SCIENTIFIC COMPANY L.L.C. | 2024 | $438,533 | Not available |
| 75H70723F80016 | ABBOTT LABORATORIES INC. | 2023 | $300,655 | Not available |
| 36C25725P0027 | GOVERNMENT SCIENTIFIC SOURCE INC | 2025 | $297,082 | Not available |
Citation facts
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING has $11,286,743 in ingested federal contract obligations across 51 award records in this naics profile.
- Source
- USAspending.gov procurement award records
- Data updated
- May 7, 2026
- Canonical URL
- https://www.govspending.us/naics/325413
Federal Contract Questions
How much federal contract spending is associated with IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING?
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING has $11,286,743 in ingested contract obligations across 51 award records.
Which relationships matter most for IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING?
ROCHE DIAGNOSTICS CORPORATION is the largest listed relationship in this profile at $2,037,903.
Which industries or buyers are most visible?
Department of Veterans Affairs is the largest listed secondary category at $6,305,165.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.